Monograph Details
|
|
Urogenital System
> Miscellaneous urogenital disorders
|
|
PHOSLO |
| Manufacturer |
|
Nabi |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Phosphate regulator. |
| Generic Name |
|
Calcium acetate 667mg (elemental calcium 169mg); tabs; gelcaps. |
| Indications |
|
Hyperphosphatemia in end stage renal failure. |
| Children |
|
Not recommended. |
| Adults |
|
1334mg with meals; usual max 2668mg per meal. Adjust dose to keep serum phosphate <6mg/dL. |
| Contraindications |
|
Hypercalcemia. |
| Precautions |
|
Monitor serum calcium and phosphorus. Pregnancy (Cat.C). |
| Interactions |
|
Avoid digitalis, calcium supplements, antacids. May inhibit tetracycline absorption. |
| Adverse Reactions |
|
Hypercalcemia, nausea. |
| How Supplied |
|
Both—200 |
|
|
|
|
